Mereo BioPharma Group plc (MREO) Logo

    Mereo BioPharma Group plc (MREO) symbol, logo with name and high resolution download options.

    Download LogoStock API
    Mereo BioPharma Group plc (MREO) logo

    Sector

    Healthcare

    Industry

    Biotechnology

    Ticker

    MREO

    Website

    mereobiopharma.com

    About Mereo BioPharma Group plc (MREO)

    Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. It develops Etigilimab, an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for use in the treatment of tumors. The company is also developing Navicixizumab, which has completed Phase 1b clinical trials for the treatment of the late line ovarian cancer; Acumapimod, a p38 MAP kinase inhibitor that is in Phase II clinical trials to treat acute exacerbations of chronic obstructive pulmonary disease; and Leflutrozole, an oral aromatase inhibitor, which is in Phase 2 trials for use in the treatment of hypogonadotropic hypogonadism. In addition, it develops rare disease product candidates, including Setrusumab, an antibody for the treatment of osteogenesis imperfecta; and Alvelestat, an oral small molecule that is in Phase II clinical trial to treat Alpha-1 anti-trypsin deficiency. The company has a license agreement with Feng Biosciences for the development and commercialization of navicixizumab; license agreement with ReproNovo for the development and commercialization of leflutrozole; and licensing agreement with AstraZeneca. Mereo BioPharma Group plc was incorporated in 2015 and is headquartered in London, United Kingdom.

    ISIN: US5894921072
    Ticker: 0A9G
    Ticker: 0A9G.L
    Ticker: A2PEYJ
    Ticker: MAH0
    Ticker: MAH0.DU
    Ticker: MAH0.F
    Ticker: MAH0.HM
    Ticker: MAH0.MU
    Ticker: MREO

    Get Mereo BioPharma Group plc (MREO) Logo via API

    Integrate this logo into your application with a single API call

    GET https://api.logostream.dev/stocks/symbol/MREO?key=YOUR_API_KEY&variant=icon
    View Full Documentation

    Why Use Our Stock Logo API?

    Fast Delivery

    <100ms response time via global CDN

    Enterprise-Ready

    99.99% uptime SLA with GDPR compliance

    Multiple Formats

    SVG, PNG, WebP - scalable to any size

    400k+ Logos

    Stocks, ETFs, Crypto, Banks, and more

    Where to Use Stock Logos

    Trading Platforms

    Real-time stock displays with instant logo loading

    Portfolio Apps

    Visualize holdings with recognizable brand logos

    Financial Dashboards

    Enhance market data with company branding

    News & Research

    Illustrate articles with accurate company logos

    Frequently Asked Questions

    Use our Stock Logo API with the ticker symbol MREO. Make a GET request to https://api.logostream.dev/stocks/symbol/MREO?key=YOUR_API_KEY to receive the logo. You can also specify format (SVG, PNG, WebP) and size parameters.

    The Mereo BioPharma Group plc (MREO) logo is available in SVG, PNG, WebP, and JPG formats. SVG is recommended for scalability. Use the format parameter to specify your preferred format, e.g., ?format=svg or ?format=png.

    With a logostream API subscription, you can use logos for display purposes in financial applications, trading platforms, dashboards, and portfolio trackers. The logos are provided for informational and display purposes within your application.

    Simply embed the API URL as an image source in your application. For example: <img src="https://api.logostream.dev/stocks/symbol/MREO?key=YOUR_API_KEY" />. The API returns optimized images with proper caching headers for fast loading.

    Need Stock Logos for Your Application?

    Access 380,000+ company logos via our simple REST API. Perfect for trading platforms, portfolio apps, and financial dashboards.

    View DocumentationRequest API Key